Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309398 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuma T Ortiz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America. Hauptthemen laut MEDLINE: Fibrosarcoma, Bone Neoplasms, Cancer Pain, Mice, Inbred C3H. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center.
Abstract (Originalsprache)
For many cancer patients tumor burden negatively impacts quality of life due to associated pain onset. Neuropathic pain is commonly associated with late cancer stages, and is resultant of tumor metastasis to bone, herein referred to as cancer-induced bone pain. Given the severe impact on quality of life and clinical treatment strategies focusing on symptom management, novel therapeutics are needed to alleviate cancer-induced bone pain and/or reduce cancer burden. In the current study we characterized a commercially available murine fibrosarcoma cell line, NCTC-2472 in vitro , which can be used to assess the capacity of novel compounds to impact cellular viability. We found that dimethyl sulfoxide, a known cytotoxic agent and common drug preparation compound, significantly decreased cell viability in a dose-related manner. We then characterized the in vivo tumor development and associated pain behavior characteristics following implantation of NCTC-2472 fibrosarcoma into male and female C3H/HeJ mice. The C3H/HeJ strain was utilized as these mice are syngeneic with NCTC-2472 fibrosarcoma and their use reduces potential implantation failure. We found that tumor development in mice resulted in the development of mechanical allodynia but not thermal hyperalgesia. Gabapentin, a clinically relevant analgesic, produced dose-related mechanical allodynia reversal. These studies provide further characterization of a cancer-induced bone pain model that can be used to examine novel compounds as anti-cancer and analgesic therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America.
- Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America.
ORCID-Profile: Yuma T Ortiz, Lance R McMahon
Förderung
- Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center
Zitieren
APA
Ortiz, Y. T., Shamir, L. G., McMahon, L. R., & Wilkerson, J. L. (2024). Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo. PLOS ONE. https://doi.org/10.1371/journal.pone.0309398
Vancouver
Ortiz YT, Shamir LG, McMahon LR, Wilkerson JL. Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo. PLOS ONE. 2024. doi:10.1371/journal.pone.0309398
BibTeX
@article{Ortiz2024,
author = {Ortiz, Yuma T and Shamir, Leila G and McMahon, Lance R and Wilkerson, Jenny L},
title = {Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309398}
}
EUVIMED